Aberrant laminin signaling drives melanocyte dedifferentiation and unveils a tractable therapeutic target in vitiligo

Fei Yang(Kao Corporation (Japan)), Ichiro Katayama(The University of Osaka)
bioRxiv (Cold Spring Harbor Laboratory)
April 14, 2025
Cited by 2


Related Papers